-
-
-
-
-
-
-
Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 10c
-
-
-
-
-
-
-
Lisata Therapeutics receives new patent for certepetide through 2040
-
-
-
-
-
-
-
Lisata Therapeutics (LSTA) and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)
-
479,484 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


